Trial intelligence / Profile preview

CAREER study (rivastigmine patch in mild to moderate Alzheimer's disease with or without white matter lesions)

KCT0000551Phase 4Recruiting

Sponsor
Ministry of Health and Welfare
Start
Jul 2011
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of rivastigmine in Alzheimer's disease (AD), sponsored by Ministry of Health and Welfare. Started Jul 2011; status: recruiting.

02

Drugs

rivastigmine
03

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on KCT0000551.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0000551.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call